We are live on ! Find out more
Walleye Trading

Walleye Trading Portfolio holdings

AUM $87.6B
1-Year Est. Return 68.17%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+68.17%
3 Year Est. Return
+183.75%
5 Year Est. Return
+176.17%
10 Year Est. Return
+1,310.54%
AUM
$35.1B
AUM Growth
+$2.22B
Cap. Flow
+$505M
Cap. Flow %
1.44%
Top 10 Hldgs %
19.95%
Holding
5,858
New
882
Increased
1,652
Reduced
1,782
Closed
956

Sector Composition

Rank Sector Weight
1 Technology 2.49%
2 Financials 1.83%
3 Consumer Discretionary 1.29%
4 Healthcare 0.95%
5 Consumer Staples 0.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMPX.WS icon
3726
Amprius Technologies Warrants
AMPX.WS
$564M
$164K ﹤0.01%
566,239
+30,991
+6% +$11K
RCM
3727
CALL
DELISTED
R1 RCM Inc. Common Stock
RCM
$164K ﹤0.01%
15,000
+1,500
+11% +$19K
CERE
3728
PUT
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$164K ﹤0.01%
+5,200
New +$147K
ODP
3729
PUT
DELISTED
ODP
ODP
$164K ﹤0.01%
3,600
-10,000
-74% -$427K
MASI
3730
DELISTED
Masimo
MASI
$164K ﹤0.01%
1,107
+517
+88% +$71.1K
SSD icon
3731
Simpson Manufacturing
SSD
$7.99B
$164K ﹤0.01%
1,845
-5,547
-75% -$485K
FATE icon
3732
CALL
Fate Therapeutics
FATE
$317M
$163K ﹤0.01%
16,200
-1,700
-9% -$31.9K
SPXS icon
3733
CALL
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$327M
$163K ﹤0.01%
730
-350
-32% -$80K
ARHS icon
3734
Arhaus
ARHS
$1.37B
$163K ﹤0.01%
+16,679
New +$146K
TGTX icon
3735
CALL
TG Therapeutics
TGTX
$7.58B
$162K ﹤0.01%
13,700
-48,300
-78% -$351K
CTKB icon
3736
Cytek Biosciences
CTKB
$621M
$162K ﹤0.01%
15,863
+5,168
+48% +$69.5K
ASTS icon
3737
CALL
AST SpaceMobile
ASTS
$21.4B
$162K ﹤0.01%
+33,600
New +$203K
TNDM icon
3738
PUT
Tandem Diabetes Care
TNDM
$1.63B
$162K ﹤0.01%
3,600
+600
+20% +$27.2K
SPXL icon
3739
CALL
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.41B
$161K ﹤0.01%
2,600
+1,600
+160% +$103K
DLCAU
3740
DELISTED
Deep Lake Capital Acquisition Corp. Unit
DLCAU
$161K ﹤0.01%
16,000
TIGR
3741
CALL
UP Fintech Holding
TIGR
$818M
$161K ﹤0.01%
47,200
+24,400
+107% +$106K
EVER icon
3742
CALL
EverQuote
EVER
$867M
$161K ﹤0.01%
+10,900
New +$102K
UCO icon
3743
CALL
ProShares Ultra Bloomberg Crude Oil
UCO
$422M
$161K ﹤0.01%
+5,300
New +$160K
STOR
3744
PUT
DELISTED
STORE Capital Corporation
STOR
$160K ﹤0.01%
5,000
-2,000
-29% -$63.5K
WOOF icon
3745
PUT
Petco
WOOF
$780M
$160K ﹤0.01%
16,900
-14,600
-46% -$150K
FBIN icon
3746
PUT
Fortune Brands Innovations
FBIN
$5.83B
$160K ﹤0.01%
2,800
+1,864
+199% +$98K
TPH
3747
CALL
DELISTED
Tri Pointe Homes
TPH
$160K ﹤0.01%
8,600
-25,300
-75% -$440K
AUDC icon
3748
AudioCodes
AUDC
$249M
$160K ﹤0.01%
+8,935
New +$172K
VRSK icon
3749
Verisk Analytics
VRSK
$23.5B
$159K ﹤0.01%
+903
New +$159K
GTLB icon
3750
PUT
GitLab
GTLB
$7.32B
$159K ﹤0.01%
3,500
-11,300
-76% -$510K

Similar funds

Walleye Trading's Q4 2022 Portfolio in Review

As of Q4 2022, Walleye Trading held 5,858 positions worth $35.1B, up 6.8% from $32.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Walleye Trading's Q4 2022 filing shows 882 new, 1,652 increased, 1,782 reduced and 956 closed positions. Its largest new stake was Microsoft: 434,280 shares worth $104M. The largest sale was NVIDIA, an estimated $58.8M.

By sector, the portfolio is most concentrated in Technology at 2.5% of assets, down from 2.5% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Walleye Trading's largest Q4 2022 buy was Microsoft: 434,280 shares worth $104M.
  • Walleye Trading added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $178M increase.
  • Walleye Trading's biggest Q4 2022 reduction was NVIDIA, cutting an estimated $58.8M.
  • Walleye Trading fully exited Social Capital Hedosophia Holdings Corp. VI in Q4 2022, selling an estimated $20.3M.
  • Walleye Trading's ten largest holdings make up 20% of its $35.1B portfolio in Q4 2022.
  • Walleye Trading opened 882 new positions and closed 956 in Q4 2022.
  • Walleye Trading's portfolio value rose 6.8% quarter-over-quarter to $35.1B.

Based on Walleye Trading's 13F filing for Q4 2022, filed 14 Feb 2023.